🇺🇸 FDA
Patent

US 10729534

Methods of treating a musculoskeletal tissue interface injury using decellularized composite tissue bioscaffolds

granted A61KA61K35/32

Quick answer

US patent 10729534 (Methods of treating a musculoskeletal tissue interface injury using decellularized composite tissue bioscaffolds) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K35/32